Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review

Shira Ronen, Steven H. Kroft, Horatiu Olteanu, Paul R. Hosking, Alexandra M. Harrington

Research output: Contribution to journalArticle

Abstract

Introduction: Carcinocythemia is a rare phenomenon defined as morphologically identifiable, circulating tumor cells in the peripheral blood. No modern case series of carcinocythemia exists in the literature. Methods: Blood smears from carcinocythemia patients were reviewed and associated clinicopathologic findings described and compared to the literature. When available, bone marrows were examined. Results: We identified 7 carcinocythemia cases over 3 years at our institution in 5 females and 2 males with a median age of 57 and compare them to 26 case reports in the literature (19 females, 10 males; median age 57). The primary neoplasms were carcinomas of breast (3 cases), lung, non-small cell (2 cases), prostate (1), and 1 case of unknown primary. Circulating tumor cells were associated with fragmentation hemolysis (2 cases), asplenic RBC changes (3 cases), and myeloid antigen expression by flow cytometry (2 cases) and were most commonly found at the feathered edge of the slide (6 cases) as single cells or in clusters. Conclusions: This represents the largest series of carcinocythemia reported. The identification of 7 cases at one institution over a 3-year period suggests carcinocythemia may becoming more common. Raising awareness of this entity and its associated clinicopathologic findings may help avoid diagnostic pitfalls in blood smear examinations and may guide timely clinical management.

Original languageEnglish (US)
Pages (from-to)69-79
Number of pages11
JournalInternational Journal of Laboratory Hematology
Volume41
Issue number1
DOIs
StatePublished - Feb 1 2019

Fingerprint

Circulating Neoplastic Cells
Blood
Tumors
Cells
Flow cytometry
Hemolysis
Prostate
Flow Cytometry
Bone
Bone Marrow
Breast Neoplasms
Antigens
Lung
Neoplasms

Keywords

  • carcinocythemia
  • circulating tumor cells
  • flow cytometry
  • microangiopathic hemolytic anemia

ASJC Scopus subject areas

  • Hematology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Carcinocythemia : A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review. / Ronen, Shira; Kroft, Steven H.; Olteanu, Horatiu; Hosking, Paul R.; Harrington, Alexandra M.

In: International Journal of Laboratory Hematology, Vol. 41, No. 1, 01.02.2019, p. 69-79.

Research output: Contribution to journalArticle

@article{58515a7346594c83a938466d2cca219f,
title = "Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review",
abstract = "Introduction: Carcinocythemia is a rare phenomenon defined as morphologically identifiable, circulating tumor cells in the peripheral blood. No modern case series of carcinocythemia exists in the literature. Methods: Blood smears from carcinocythemia patients were reviewed and associated clinicopathologic findings described and compared to the literature. When available, bone marrows were examined. Results: We identified 7 carcinocythemia cases over 3 years at our institution in 5 females and 2 males with a median age of 57 and compare them to 26 case reports in the literature (19 females, 10 males; median age 57). The primary neoplasms were carcinomas of breast (3 cases), lung, non-small cell (2 cases), prostate (1), and 1 case of unknown primary. Circulating tumor cells were associated with fragmentation hemolysis (2 cases), asplenic RBC changes (3 cases), and myeloid antigen expression by flow cytometry (2 cases) and were most commonly found at the feathered edge of the slide (6 cases) as single cells or in clusters. Conclusions: This represents the largest series of carcinocythemia reported. The identification of 7 cases at one institution over a 3-year period suggests carcinocythemia may becoming more common. Raising awareness of this entity and its associated clinicopathologic findings may help avoid diagnostic pitfalls in blood smear examinations and may guide timely clinical management.",
keywords = "carcinocythemia, circulating tumor cells, flow cytometry, microangiopathic hemolytic anemia",
author = "Shira Ronen and Kroft, {Steven H.} and Horatiu Olteanu and Hosking, {Paul R.} and Harrington, {Alexandra M.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1111/ijlh.12924",
language = "English (US)",
volume = "41",
pages = "69--79",
journal = "International Journal of Laboratory Hematology",
issn = "1751-5521",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Carcinocythemia

T2 - A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review

AU - Ronen, Shira

AU - Kroft, Steven H.

AU - Olteanu, Horatiu

AU - Hosking, Paul R.

AU - Harrington, Alexandra M.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Introduction: Carcinocythemia is a rare phenomenon defined as morphologically identifiable, circulating tumor cells in the peripheral blood. No modern case series of carcinocythemia exists in the literature. Methods: Blood smears from carcinocythemia patients were reviewed and associated clinicopathologic findings described and compared to the literature. When available, bone marrows were examined. Results: We identified 7 carcinocythemia cases over 3 years at our institution in 5 females and 2 males with a median age of 57 and compare them to 26 case reports in the literature (19 females, 10 males; median age 57). The primary neoplasms were carcinomas of breast (3 cases), lung, non-small cell (2 cases), prostate (1), and 1 case of unknown primary. Circulating tumor cells were associated with fragmentation hemolysis (2 cases), asplenic RBC changes (3 cases), and myeloid antigen expression by flow cytometry (2 cases) and were most commonly found at the feathered edge of the slide (6 cases) as single cells or in clusters. Conclusions: This represents the largest series of carcinocythemia reported. The identification of 7 cases at one institution over a 3-year period suggests carcinocythemia may becoming more common. Raising awareness of this entity and its associated clinicopathologic findings may help avoid diagnostic pitfalls in blood smear examinations and may guide timely clinical management.

AB - Introduction: Carcinocythemia is a rare phenomenon defined as morphologically identifiable, circulating tumor cells in the peripheral blood. No modern case series of carcinocythemia exists in the literature. Methods: Blood smears from carcinocythemia patients were reviewed and associated clinicopathologic findings described and compared to the literature. When available, bone marrows were examined. Results: We identified 7 carcinocythemia cases over 3 years at our institution in 5 females and 2 males with a median age of 57 and compare them to 26 case reports in the literature (19 females, 10 males; median age 57). The primary neoplasms were carcinomas of breast (3 cases), lung, non-small cell (2 cases), prostate (1), and 1 case of unknown primary. Circulating tumor cells were associated with fragmentation hemolysis (2 cases), asplenic RBC changes (3 cases), and myeloid antigen expression by flow cytometry (2 cases) and were most commonly found at the feathered edge of the slide (6 cases) as single cells or in clusters. Conclusions: This represents the largest series of carcinocythemia reported. The identification of 7 cases at one institution over a 3-year period suggests carcinocythemia may becoming more common. Raising awareness of this entity and its associated clinicopathologic findings may help avoid diagnostic pitfalls in blood smear examinations and may guide timely clinical management.

KW - carcinocythemia

KW - circulating tumor cells

KW - flow cytometry

KW - microangiopathic hemolytic anemia

UR - http://www.scopus.com/inward/record.url?scp=85053471510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053471510&partnerID=8YFLogxK

U2 - 10.1111/ijlh.12924

DO - 10.1111/ijlh.12924

M3 - Article

C2 - 30216684

AN - SCOPUS:85053471510

VL - 41

SP - 69

EP - 79

JO - International Journal of Laboratory Hematology

JF - International Journal of Laboratory Hematology

SN - 1751-5521

IS - 1

ER -